Foamix Pharmaceuticals misses by $0.02, misses on revenue

• Foamix Pharmaceuticals (NASDAQ:FOMX): Q2 EPS of -$0.27 misses by $0.02.
• Revenue of $0.75M (+581.8% Y/Y) misses by $0.35M.
• Press Release